Lidothol
Product Images NDC 50090-3470

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lidothol (NDC 50090-3470). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig1 (Fig1)

A pharmacokinetic line graph showing plasma lidocaine concentration (ng/mL) over time (hours) up to 72 hours. The graph features three peak cycles of lidocaine plasma levels rising and falling, indicating periodic changes in concentration.*

FDA Label Image

Label Image (Lbl500903470)

LIDOTHOL lidocaine patch 5% label from A-S Medication Solutions. The adhesive patch is for topical use with storage instructions to keep in a cool, dry place below 77 degrees Fahrenheit and protection from excessive moisture or sunlight. The label includes lot number and distributor information for Bedford, Ohio, and manufacturer details for TEBIAN Pharmaceuticals in India. The package contains 15 patches.*

FDA Label Image

Lidocaine (Lidocaine)

Chemical structure diagram of the active ingredient in LIDOTHOL by A-S Medication Solutions. The structure shows a benzene ring substituted with two methyl groups and an amide linkage connecting to an ethyl-substituted nitrogen group.*

FDA Label Image

Menthol (Menthol)

Chemical structure diagram showing a six-membered cyclohexane ring substituted with a hydroxyl group and two methyl groups. This image represents the chemical structure of the active ingredient in LIDOTHOL from A-S Medication Solutions.*

FDA Label Image

Mentholpath (Pathway)

A metabolic pathway diagram illustrating the proposed metabolism of menthol. The figure shows menthol in the center with arrows pointing to various metabolites including para-menthane-3,7-diol, para-menthane-3,9-diol, para-menthane-3,8-diol, 3,8-dihydro-para-menthane-7-carboxylic acid, and menthol-9-carboxylic acid. It indicates enterohepatic circulation and excretion routes to urine and feces, including a glucuronide conjugate.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.